双特异性抗体在多发性骨髓瘤中的演进
The evolution of bispecific antibodies in multiple myeloma.
46.3分
★★★☆☆
站内排序·非疗效
ALL SOURCES
The evolution of bispecific antibodies in multiple myeloma.
Structure and function of therapeutic antibodies approved by the US FDA in 2023.
共 2 条
MEMBER ACCOUNT
登录成功会直接打开下一页。